Fable
3 known investors
Fable Therapeutics develops biologics for metabolic disease treatment, specifically targeting the ActR2 pathway to address obesity and related comorbidities through protein engineering. The company is advancing a pipeline of therapeutic candidates designed to reduce body weight and fat while preserving muscle and improving metabolic health.
BiotechHealthtechMedical Devices
Investors · 3
In the news
- Selling Cyber: Anthropic's Fable 5 Raises Security Tradeoffsbankinfosecurity.com · 2026
- Claude Fable 5 Free Until July 12: The Fundraising Playbook for Founders (2026)thevccorner.com · 2026
- Fable Security Raises $31M in Fundingfinsmes.com · 2025
- Fable Food Co Raises US$8.5M in Series A Funding - FinSMEsfinsmes.com · 2023